Related references
Note: Only part of the references are listed.Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2
Hasan Hashem et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2
Hasan Hashem et al.
BLOOD (2017)
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency
Tal Ben-Ami et al.
JOURNAL OF PEDIATRICS (2016)
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency
Lien Van Eyck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
R Caorsi et al.
Pediatric Rheumatology (2015)
The deficiency of adenosine deaminase type 2-results of therapeutic intervention
A Ombrello et al.
Pediatric Rheumatology (2015)
Cytokine and Chemokine Patterns Across 100 Days after Hematopoietic Stem Cell Transplantation in Children
Joseph DiCarlo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Bortezomib for Refractory Autoimmunity in Pediatrics
Pooja Khandelwal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Mutant ADA2 in Vasculopathies
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Early- Onset Stroke and Vasculopathy Associated with Mutations in ADA2
Qing Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy
Paulina Navon Elkan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mutations in CECR1 associated with a neutrophil signature in peripheral blood
Alexandre Belot et al.
PEDIATRIC RHEUMATOLOGY (2014)
Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation
J Andersen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Share Paper
